Actively Recruiting
Prospective Evaluation of Cornerstone Robotics Sentire Surgical System in Major Gastrointestinal and Urologic Surgery
Led by Chinese University of Hong Kong · Updated on 2025-04-16
90
Participants Needed
1
Research Sites
105 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Robotic assisted surgery has been performed for more than two decades with good success and safety profile. However, there was only one dominating robotic surgical system available in the past which led to high cost for robotic surgery. Recently, a new robotic surgical system (Sentire Robotic Surgical System) was introduced by researchers of The Chinese University of Hong Kong (CUHK). This new robotic surgical system aims to achieve similar outcomes and standards of robotic surgery performed using the dominating system but with a significantly lower cost. The technologic innovation and development of this new robotic system is made by the Cornerstone Robotics Limited, which is based in Hong Kong. In a pilot clinical study conducted at Prince of Wales Hospital involving 55 patients, the Sentire Robotic Surgical System had demonstrated high success rate with minimal complications in patients who underwent robotic colorectal, upper gastrointestinal, and urologic surgery. Researchers of CUHK would therefore like to conduct another prospective study to further evaluate the efficacy and safety of Sentire Surgical System C1000 in major gastrointestinal and urologic surgery with expanded indications. It is believed that the results of this study will provide data to support its use for wide range of procedures with minimal access trauma, for the benefit of patients. This system will also lead to a wider range of clinical application for minimally invasive surgery with a cost-effective model.
CONDITIONS
Official Title
Prospective Evaluation of Cornerstone Robotics Sentire Surgical System in Major Gastrointestinal and Urologic Surgery
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Body mass index less than 35 kg/m2
- Suitable for minimally invasive surgery for listed diseases
- Willing to participate by giving informed consent
- Adenocarcinoma or large adenoma in colorectum suitable for minimally invasive surgery
- Mid or low rectal adenocarcinoma within 12 cm of anal verge
- Clinically diagnosed with untreated, uncomplicated rectal prolapse or enterocele
- Clinically diagnosed with nonmetastatic prostate adenocarcinoma
- Clinically diagnosed with nonmetastatic kidney cancer
- Clinically diagnosed with nonmetastatic bladder cancer
- Clinically diagnosed with hiatal hernia and/or gastroesophageal reflux disease suitable for fundoplication
- Clinical diagnosis of gastric tumor (adenocarcinoma or GIST) suitable for minimally invasive gastrectomy
- Clinical diagnosis of esophageal carcinoma suitable for minimally invasive esophagectomy
- Symptomatic gallbladder stones requiring laparoscopic cholecystectomy
You will not qualify if you...
- Contraindication to general anesthesia
- Severe illness shortening life expectancy or increasing intervention risk
- Untreated active infection
- Noncorrectable bleeding disorder
- Another malignancy or distant metastasis
- Emergency surgery
- Mentally disabled or pregnancy
- Tumor classified as T4 or recurrent tumor for colorectal surgery
- Extensive previous abdominal surgery preventing minimally invasive surgery
- T4 tumor or circumferential margin involvement for transanal total mesorectal excision
- Tumor needing multivisceral or abdominoperineal resection
- T1 tumor treatable by local excision
- Previous prostate surgery
- Previous kidney surgery on the same side
- Complex kidney anatomy (e.g., horseshoe kidney)
- Previous laparotomy preventing minimally invasive surgery for esophageal, gastric, or hiatal surgeries
- Esophageal carcinoma after chemoradiotherapy needing salvage esophagectomy
- Acute cholecystitis
- Previous abdominal surgery preventing laparoscopic cholecystectomy
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Prince of Wales Hospital, The Chinese University of Hong Kong
Hong Kong, China
Actively Recruiting
Research Team
S
Simon SM Ng, MD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
TREATMENT
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here